Hoth Therapeutics, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for HOTH, updated each market day.
HOTH AI Sentiment
AI predicts Hoth Therapeutics, Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Hoth Therapeutics, Inc. Common Stock
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA). Its current assets are focused in treating cancer, skin toxicities, Alzheimer's, and weight loss.
Sector
Exchange
Market Cap
$10,321,276
Cap Tier
Employees
3
Headquarters
NEW YORK, NY
Listed Since
Feb. 15, 2019
Website
HOTH Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
HOTH Volatility
Hoth Therapeutics, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
